| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33a6e0ea986466fcb5b6621fa67f6f8d |
| publicationDate |
2019-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190017465-A |
| titleOfInvention |
Markers for diagnosing prognosis of patient of clear cell renal cell carcinoma |
| abstract |
The present invention relates to a marker for the prognosis diagnosis of a kidney cancer patient. In the case of a kidney cancer patient, since the mutation of the gene of the present invention and the survival rate of the patient, or the mutation of the gene of the present invention and the recurrence rate of kidney cancer, Variants of the genes of the present invention can be used as markers to predict a patient's prognosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021172853-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210110184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210108160-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022124219-A1 |
| priorityDate |
2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |